HIFU Lifting in Korea — Shurink & V-RO Focused Ultrasound at RE:BERRY Incheon Airport

HIFU: The Only Non-Invasive SMAS Treatment

The SMAS (Superficial Musculoaponeurotic System) is the key to facial lifting. This fibromuscular layer connects the facial muscles to the overlying skin; when it descends, the entire soft tissue envelope follows. Surgical facelifts (rhytidectomy) physically reposition the SMAS through open incisions — the gold standard for lifting but requiring general anesthesia, weeks of recovery, and surgical risks. HIFU (High-Intensity Focused Ultrasound) is the only non-invasive technology that reaches the SMAS. By converging acoustic waves to a focal point at 4.5mm depth, HIFU raises tissue temperature to 60-70 degrees Celsius within a 1mm zone — creating a thermal coagulation point that triggers the same wound-healing cascade as surgical trauma, but without surface incision. The surrounding tissue is completely unaffected because ultrasound energy is below threshold except at the precise focal convergence.

Korean HIFU Innovation: Shurink and V-RO

Korea’s HIFU innovation centers on two platforms: Shurink (by Classys, Korea) and V-RO (by various Korean manufacturers). Shurink delivers dot-pattern TCPs — each shot creates one thermal coagulation point at the programmed depth. This allows precise targeting of specific anatomical zones. V-RO introduces linear scanning technology — the focal point moves along a line during each shot, creating a continuous row of TCPs in a single pass. V-RO’s advantage: 30-40% faster treatment time, more uniform energy distribution. Both achieve equivalent tissue temperatures and depths. Korean physicians have extensive experience with both, selecting based on treatment goals.

Neocollagenesis: From TCP to New Collagen

Each TCP undergoes a predictable healing sequence: (1) Immediate phase (0-24h) — heat-denatured collagen contracts by 10-15%, providing mild instant tightening; (2) Inflammatory phase (1-7 days) — inflammatory mediators recruit fibroblasts to the TCP site; (3) Proliferative phase (1-8 weeks) — fibroblasts deposit Type III collagen, initiating tissue repair; (4) Remodeling phase (2-6 months) — Type III collagen matures to Type I collagen, the structural protein responsible for tensile strength. This remodeling phase is why HIFU results improve progressively over months. Histological studies confirm persistent new collagen at treated depths for 12+ months (Alam et al., 2010; doi:10.1016/j.jaad.2009.06.039). Korean studies specifically demonstrate that HIFU produces measurable tissue displacement of 1.5-3mm in the lifting vector (Suh et al., 2011; doi:10.1111/j.1524-4725.2011.02128.x).

HIFU in Asian Skin: Korean Clinical Evidence

Korean researchers have published extensively on HIFU outcomes in Asian skin (Fitzpatrick III-IV). Suh et al. (2011) demonstrated significant tissue tightening in Korean patients with no cases of burns, scarring, or post-inflammatory hyperpigmentation — confirming HIFU’s excellent safety profile in Asian skin. The ultrasound mechanism is entirely melanin-independent, making HIFU equally safe and effective across all skin types. This melanin independence is a primary reason HIFU became Korea’s most popular lifting treatment — unlike light-based devices (IPL, laser), HIFU carries zero PIH risk. Park et al. (2016) specifically demonstrated HIFU efficacy for lower face rejuvenation in Korean patients, with 78% showing significant improvement at 6-month follow-up (doi:10.5021/ad.2016.28.2.175).

References: Alam M et al. Ultrasound Tightening of Facial and Neck Skin. J Am Acad Dermatol. 2010;62(2):262-271. doi:10.1016/j.jaad.2009.06.039 | Suh DH et al. Intense Focused Ultrasound in Asian Skin. Dermatol Surg. 2011;37(11):1595-602. doi:10.1111/j.1524-4725.2011.02128.x | Park MY et al. Non-Invasive Rejuvenation with HIFU in Korean Population. Ann Dermatol. 2016;28(2):175-182. doi:10.5021/ad.2016.28.2.175 | Fabi SG. Noninvasive Skin Tightening. Clin Cosmet Investig Dermatol. 2015;8:47-52. doi:10.2147/CCID.S69118 | Brobst RW et al. Noninvasive Treatment of the Neck. Facial Plast Surg Clin North Am. 2014;22(2):191-202. doi:10.1016/j.fsc.2014.01.005